Palliatieve behandeling voor slokdarmkanker met passageklachten: gunstiger uitkomsten van eenmalige inwendige brachytherapie dan van plaatsing van een zelfexpanderende stent; multicentrisch, gerandomiseerd onderzoek

Autor: Homs, M. Y. V., Steyerberg, E. W., Eijkenboom, W. M. H., Tilanus, H. W., Stalpers, L. J. A., Bartelsman, J. F. W. M., van Lanschot, J. J. B., Wijrdeman, H. K., Mulder, C. J. J., Reinders, J. G., Boot, H., Aleman, B. M. P., Kuipers, E. J., Siersema, P. D.
Přispěvatelé: CCA -Cancer Center Amsterdam, Radiotherapy, Gastroenterology and Hepatology, Surgery
Jazyk: Dutch; Flemish
Rok vydání: 2005
Předmět:
Zdroj: Nederlands tijdschrift voor geneeskunde, 149(50), 2800-2806. Bohn Stafleu van Loghum
ISSN: 0028-2162
Popis: OBJECTIVE: To compare the results of single-dose internal irradiation (brachytherapy) and self-expanding metal stent placement in the palliation of oesophageal obstruction due to cancer of the oesophagus. DESIGN: Randomised trial. METHOD: In the period from December 1999-Jun 2002, 209 patients with dysphagia due to inoperable carcinoma of the oesophagus were randomised to placement of an Ultraflex stent (n = 108) or single-dose (12 Gy) brachytherapy (n = 101). Primary outcome was relief of dysphagia; secondary outcomes were complications, persistent or recurrent dysphagia, health-related quality of life, and costs. Patients were followed up by monthly home visits from a specialised nurse. RESULTS: Dysphagia improved more rapidly after stent placement than after brachytherapy, but long-term relief of dysphagia was better after brachytherapy. Stent placement resulted in more complications than did brachytherapy (36/108 (33%) versus 21/101 (21%); p = 0.02), due mainly to an increased incidence of late haemorrhage in the stent group (14 versus 5; p = 0.05). The groups did not differ with regard to the incidence of persistent or recurrent dysphagia or median survival (p > 0.20). In the long term, quality-of-life scores were higher in the brachytherapy group. Total medical costs were also similar for both treatments: Euro 8,215 for stent placement and Euro 8,135 for brachytherapy. CONCLUSION: Brachytherapy provided better long-term relief of dysphagia than did stent placement and also produced fewer complications. Brachytherapy is therefore recommended as the preferred treatment for the palliation of dysphagia due to oesophageal cancer
Databáze: OpenAIRE